INKT CIK: 1840229

MiNK Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−12.8
FY22:
−18.9
FY23:
−15.8
FY24:
−9.56
FY25:
−5.93
Change from FY21 to FY23
millions USD
FY21:
−0.25
FY22:
−0.25
FY23:
−0.07
FY24:
–
FY25:
–
Change from FY21 to FY25
millions USD
FY21:
49.3
FY22:
−0.16
FY23:
−0.41
FY24:
10.8
FY25:
14.7
millions USD
FY21:
36.2
FY22:
−19.3
FY23:
−16.3
FY24:
1.21
FY25:
8.78
(positive)
Change from FY21 to FY23
millions USD
FY21:
−13.1
FY22:
−19.1
FY23:
−15.8
FY24:
–
FY25:
–

All amounts in millions USD Data source:SEC EDGAR